Melanny Ika Sulistyowati, - and Nugroho A E, - and Putra G S, - and Juni Ekowati, - and Tutuk Budiati, - (2016) Syntheses, Molecular Docking Study and Anticancer Activity Examination of p-Methoxycinnamoyl Hydrazides. International Journal of Pharmaceutical and Clinical Research, 8 (6). pp. 623-627. ISSN 0975 1556
Text (FULLTEXT)
Artikel C-12.pdf Download (4MB) |
|
Text (PEER REVIEW)
Validasi C-12.pdf Download (1MB) |
|
Text (SIMILARITY)
C-12 Result Rev.pdf Download (1MB) |
|
Text (PEER REVIEW (REV.))
Validasi C-12 rev.pdf Download (1MB) |
|
Text (FULLTEXT (MIS))
C-09 Artikel.pdf Download (4MB) |
|
Text (PEER REVIEW (MIS))
c9.pdf Download (1MB) |
|
Text (SIMILARITY (MIS))
C-09 Similarity.pdf Download (1MB) |
|
Text (KORESPONDENSI (MIS))
BUKTI KOREFPONDENSI C9.pdf Download (526kB) |
Abstract
In this study, we attempted to develop a potential anticancer drug by synthesizing some of p-methoxycinnamoyl hidrazides. The compounds were synthesized from the ethyl p-methoxycinnamate (EPMC), isolated from rhizome of Kaemferia galanga Linn. The structures of the compounds were confirmed by UV-vis spectrophotometry, 1H-NMR, 13C-NMR, FTIR, and MS spectroscopic methods. The study was followed by anticancer activity evaluation of the compounds by in silico study using Molegro® ver. 5.5 and by in vitro assay against human breast cancer cells (T47D) by 3-(4,5-Dimethylthiazol2-yl)-2-5-Diphenyltetrazolium Bromide (MTT) method. The yield of derivatives of p-methoxycinnamoylhidrazide was around 25 to 90%. The result showed that 3-(4-methoxyphenyl)-N'-(3-(4-methoxyphenyl) acryloyl) acrylohydrazide has the highest value of rerank score (-124.81). In addition, from the in vitro assay, it was revealed that 2-hydroxybenzohydrazide has the lowest IC50 (0.2 x 106 nM) against T47D as the most effective compound than the others. p-Methoxycinnamoyl hidrazides have been synthesized as low as 25% yields. Among the tested compounds, 2-hydroxybenzohydrazide is the most effective compound against T47D (human breast cancer) cell line in vitro. While in silico study result showed that 3-(4-methoxyphenyl)-N'-(3-(4-methoxyphenyl) acryloyl)acrylo- hydrazide has better activity than the lead compound, EPMC.
Item Type: | Article | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uncontrolled Keywords: | ethyl p-methoxycinnamate, hydrazides, anticancer, molecular docking, MTT assay | ||||||||||||
Subjects: | R Medicine R Medicine > RS Pharmacy and materia medica |
||||||||||||
Creators: |
|
||||||||||||
Depositing User: | Mr M. Fuad Sofyan | ||||||||||||
Date Deposited: | 29 Jun 2020 06:46 | ||||||||||||
Last Modified: | 22 Dec 2021 00:39 | ||||||||||||
URI: | http://repository.unair.ac.id/id/eprint/95745 | ||||||||||||
Sosial Share: | |||||||||||||
Actions (login required)
View Item |